Advertisement
Central Surgical Association| Volume 82, ISSUE 4, P452-459, October 1977

Correlation of immune responses with Dukes classification in colorectal carcinoma

  • Andre V. Jubert
    Correspondence
    Reprint requests: Andre V. Jubert, M.D., Department of Oncology, Saint Mary's Hospital, Grand Rapids, MI 49503.
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • Timothy M. Talbott
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • W.Patrick Mazier
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • John M. MacKeigan
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • Manuel M. Campos
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • Howard G. Benjamin
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • James P. Muldoon
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • James A. Ferguson
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • Theodore M. Maycroft
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
  • Harold E. Bowman
    Affiliations
    From the Departments of Oncology and Pathology, Saint Mary's Hospital Grand Rapids, Mich. USA

    From the Departments of Oncology and Pathology, Ferguson-Droste-Ferguson Hospital, Grand Rapids, Mich. USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      In vitro studies have reported a lack of mesenteric lymph node reactivity against autochthonous colon carcinoma cells. This study is designed to verify this lack of reactivity and to correlate its possible relationship with the patients' Dukes classification. Blastogenic reactivity of peripheral blood lymphocytes (PBLs) and lymph node lymphocytes (LNLs) to phytohemagglutinin (PHA), allogenic leukocytes in mixed leukocyte culture (MLC), pokeweed mitogen (PWM), Streptolysin-O (SLO), and to autochthonous tumor cells (ATCs) was evaluated in 45 patients with colorectal carcinoma at the time of primary resection of their lesions and was reported as stimulation index (SI). A SI of greater than 3 was considered to be significant. Five of these patients had Dukes A; 22 had Dukes B; 12 had Dukes C; and six had Dukes D lesions. Both PBLs and LNLs in Dukes D reacted vigorously to PHA and PWM. There was a significant difference between PBLs and LNLs in MLC for both Dukes B and C (p < 0.05), and at all stages LNLs seemed to be more reactive than PBL to allogeneic leukocytes. PBLs reacted specifically to ATCs in Dukes B, C, and D (13%, 33%, and 33%, respectively), but failed to react in Dukes A; whereas LNLs responded to ATCs with SI of greater than 3 only in Dukes B (26%). A comparably small percentage of PBLs and LNLs responded to SLO in Dukes A, B, and C, whereas no response to SLO was observed in Dukes D. In conclusion, a dichotomy of response seemed to be evident in that the nonspecific reactivity to PHA and PWM seemed to be unrelated to the patients' Dukes classification, but some degree of correlation seemed to be present between the patient's classification and the reactivity to SLO, MLC, and ATCs. The specific reactivity to ATCs may be due to the level of antigenicity and immunogenicity of the tumor cells.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ambus U.
        • Mavligit G.M.
        • Gutterman J.U.
        • et al.
        Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
        Int J Cancer. 1974; 14: 291
        • Buda J.A.
        • Suciu-Foca N.
        • Blomain E.
        • et al.
        Impaired cell-mediated immunity in patients with cancer.
        J Surg Oncol. 1975; 7: 525
        • Chess L.
        • MacDermott R.P.
        • Schlossman S.F.
        Immunologic functions of isolated human lymphocyte subpopulations. II. Antigens trigering of T and B cells in vitro.
        J Immunol. 1974; 113: 1122
        • Currie G.A.
        • Bagshawe K.
        Tumor-specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
        Br J Cancer. 1969; 23: 141
        • Deodhar S.D.
        • Crile Jr., G.
        • Esselstyn Jr., C.B.
        Study of the tumor cell-lymphocyte interaction in patients with breast cancer.
        Cancer. 1972; 29: 1321
        • Ende N.
        • Summers K.C.
        Antigens of lymph node cells absent from peripheral lymphocytes.
        Transplant. 1970; 9: 414
        • Fisher B.
        • Saffer E.
        • Fisher E.R.
        Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells.
        Cancer. 1974; 33: 631
        • Greaves M.F.
        • Bauminger S.
        Activation of T and B lymphocytes by insoluble phytomitogens.
        Nature [New Biol]. 1972; 235: 67
        • Gutterman J.U.
        • Mavligit G.M.
        • McCredie K.B.
        • et al.
        Antigen solubilized from human leukemia-lymphocyte stimulation.
        Science. 1972; 177: 1114
        • Hammond W.G.
        • Rolley R.T.
        Retained regional lymph nodes: Effect on metastases and recurrence after tumor removal.
        Cancer. 1970; 25: 368
        • Haskill J.S.
        • Yamamura Y.
        • Radov L.
        • et al.
        Are peripheral and in situ tumor immunity related?.
        Ann NY Acad Sci. 1976; 276: 373
        • Hellström I.
        • Sjögren H.O.
        • Warner G.
        • et al.
        Mediated tumor immunity by sera from patients with growing neoplasms.
        Int J Cancer. 1976; 7: 226
        • Herberman R.B.
        • Campbell Jr., D.A.
        • Oldham R.K.
        • et al.
        Immunogenicity of tumor antigens.
        Ann NY Acad Sci. 1970; 276: 26
        • Jehn U.W.
        • Nathanson L.
        • Schwartz R.S.
        • et al.
        In vitro lymphocyte stimulation by a soluble antigen from a malignant melanoma.
        N Engl J Med. 1970; 283: 329
        • Jubert A.V.
        • Lee E.T.
        • Hersh E.M.
        • et al.
        Effects of surgery, anesthesia, and intraoperative blood loss on immunocompetence.
        J Surg Res. 1973; 15: 399
        • Mavligit G.M.
        • Gutterman J.U.
        • McBride C.M.
        • et al.
        Cell-mediated immunity to human solid tumors: In vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens.
        Natl Cancer Inst Monogr. 1973; 37: 167
        • Mavligit G.M.
        • Jubert A.V.
        • Gutterman J.U.
        • et al.
        Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon.
        Surg Gynecol Obstet. 1974; 139: 409
        • Nairn R.C.
        • Nind A.P.P.
        • Guli E.P.G.
        • et al.
        Immunological reactivity in patients with carcinoma of the colon.
        Br Med J. 1971; 4: 706
        • Owen F.L.
        • Fanger M.W.
        Studies on the human T-lymphocyte population. I. The development and characterization of a specific anti-human T-cell antibody.
        J Immunol. 1974; 113: 1128
        • Pilch Y.H.
        • Bard D.S.
        • Ramming K.P.
        The role of regional lymph nodes in the development of host immunological response to tumors.
        Am J Roentgenol Radium Ther Nucl Med. 1971; 111: 48
        • Stjernswärd J.
        • Vánky F.
        Stimulation of lymphocytes by autochthonous cancer.
        Natl Cancer Inst Monogr. 1972; 35: 237
        • Vánky F.
        • Stjernswärd J.
        • Nilsonne U.
        • et al.
        Differences in the tumor associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma patients.
        J Natl Cancer Inst. 1973; 51: 17
        • Zoschke D.C.
        • Bach F.H.
        Specificity of allogeneic cell recognition by human lymphocytes in vitro.
        Science. 1971; 172: 1350